✦ LIBER ✦

PDB26 COST-EFFECTIVENESS OF ROSIGLITAZONE COMBINATION THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES IN THE CZECH REPUBLIC

✍ Scribed by T Doležal; J Skoupá; MJ Taylor; S Whitehead; V Rausova; P Pavlikova

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB31 THE COST OF TYPE 2 DIABETES MELLIT

✍ T Doležal; Z Pisarikova; D Bartaskova 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

PDB52 LONG-TERM COST-EFFECTIVENESS OF LI

✍ T Dolezal; M Niewada; K Rychna; M Czech 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB26 COST-EFFECTIVENESS OF ROSIGLITAZON

✍ MJ TaylorJ; A Bagust; JA PereiraA; S Mendes da Costa; S Beale; A Shearer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PDB77 QUALITY OF TREATMENT OF DIABETES M

✍ T Dolezal; M Kvapil; A Petrikova 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB41 COST-EFFECTIVENESS OF LIRAGLUTIDE

✍ A Ilavska; V Uliciansky; W Wrona; J Lacka; M Czech 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Cost-effectiveness of liraglutide versus

✍ Lee, W.C.; Conner, C.; Hammer, M. 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 311 KB